TGFB1 and neoplasm: Our in vivo studies further support the important role of TGF-β in tumorigenesis, since the expression of dominant-negative TGF-β receptors, which disrupts TGF-β signaling, significantly delayed initial LM3 tumor growth in syngeneic mice.